// STATE LEGISLATION TRACKER

Ohio HB 455 — Regards the operation of public schools and the DEW

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Ohio
Bill: HB 455
Filed: 2025-09-17
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Ohio HB455 appears to concern public schools and the Ohio Department of Education and Workforce. Based on the title and subjects provided, it does not appear to affect compounded peptides, prescribing, telehealth care, clinician scope, FDA compounding rules, controlled substances, or prescription monitoring.

Key Points

No apparent change to peptide prescribing or access
No apparent impact on compounded peptide pharmacies
No telehealth, NP, or naturopathic scope signal
No FDA 503A/503B or PDMP signal in the title

What to Watch For

Note If later bill text adds health services in schools, review for prescribing or medication-administration language.

Note Current peptide relevance appears absent from the available title and subjects.

Where the Bill Stands

The provided source says the latest action refetch failed, so the bill's current procedural status cannot be confirmed from the available data.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws